COMPASS Pathways Revenue and Competitors
Estimated Revenue & Valuation
- COMPASS Pathways's estimated annual revenue is currently $51.1M per year.
- COMPASS Pathways's estimated revenue per employee is $174,348
- COMPASS Pathways's total funding is $109M.
- COMPASS Pathways's current valuation is $747M. (January 2022)
Employee Data
- COMPASS Pathways has 293 Employees.
- COMPASS Pathways grew their employee count by -8% last year.
COMPASS Pathways's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & Co-Founder | Reveal Email/Phone |
2 | VP - Value and Outcomes Research | Reveal Email/Phone |
3 | VP, Legal, Intellectual Property | Reveal Email/Phone |
4 | SVP, Regulatory Affairs | Reveal Email/Phone |
5 | VP; Market Access & Government Affairs | Reveal Email/Phone |
6 | SVP | Reveal Email/Phone |
7 | VP Business & Corporate Development | Reveal Email/Phone |
8 | SVP, Clinical Operations | Reveal Email/Phone |
9 | VP, Digital Health Research | Reveal Email/Phone |
10 | VP, Legal, Head Intellectual Property | Reveal Email/Phone |
COMPASS Pathways Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $10.8M | 50 | -4% | N/A | N/A |
#2 | $42.8M | 144 | 5% | N/A | N/A |
#3 | $10.8M | 50 | -26% | N/A | N/A |
#4 | $54.6M | 184 | 3% | N/A | N/A |
#5 | $62.4M | 210 | 6% | N/A | N/A |
#6 | $27.8M | 103 | 11% | N/A | N/A |
#7 | $6.9M | 32 | -20% | N/A | N/A |
#8 | $268.4M | 710 | 2% | N/A | N/A |
#9 | $102.3M | 303 | 5% | N/A | N/A |
#10 | $15.3M | 63 | -32% | N/A | N/A |
What Is COMPASS Pathways?
COMPASS Pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first major initiative is developing psilocybin therapy through late-stage clinical trials in the EU and US for patients with treatment-resistant depression. We are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
keywords:N/A
$109M
Total Funding
293
Number of Employees
$51.1M
Revenue (est)
-8%
Employee Growth %
$747M
Valuation
N/A
Accelerator
COMPASS Pathways News
COMPASS Pathways plc ( CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation...
London, UK 20 April 2022. COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient...
COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based...
Eagerly awaited results of the largest-ever study of psilocybin were announced Tuesday, with Compass Pathways revealing the psychedelic drug was highly efficacious as a therapy for treatment-resistant depression. Still, the company’s stock price dropped 16.4% by the close of trading, perhaps bec ...
Largest randomised, controlled, double-blind psilocybin therapy study ever completed shows rapid and sustained response for patients receiving a single dose of COMP360 psilocybin with psychological support COMPASS management team to host an investor conference call today at 1.00pm UK (8.00am ...
Other Companies in Westminster
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $67.3M | 310 | 16% | $180.7M |
#2 | $35M | 315 | -1% | N/A |
#3 | $35M | 332 | 30% | N/A |
#4 | $87.6M | 342 | 33% | N/A |
#5 | $118.1M | 350 | 9% | N/A |